Initial studies using aliphatic beta-nitro alcohols for therapeutic corneal cross-linking

David C Paik1, Quan Wen, Richard E Braunstein

  • 1Department of Ophthalmology, Edward S Harkness Eye Institute, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA.

Summary

New beta-nitro alcohols show promise as topical stiffening agents for keratoconus, offering better corneal cross-linking than UV-A riboflavin (UVAR) with minimal impact on light transmission.